Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID - 19 and Advanced Gastro-intestinal Cancer Treatment

NCT04686747 is registered in ClinicalTrials.gov with S.M. Misericordia Hospital as lead sponsor.

NCT NCT04686747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04686747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID - 19 and Advanced Gastro-intestinal Cancer Treatment
Lead sponsor
S.M. Misericordia Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
June 30, 2021
Enrollment
2,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, esophagus cancer, gastric cancer, pancreatic cancer